By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TRACON Pharmaceuticals, Inc. 

4510 Executive Drive
Suite 330
San Diego  California  92121  U.S.A.
Phone: 858-550-0780 Fax: 858-550-0786


SEARCH JOBS


Industry
Biotechnology






Company News
TRACON Pharmaceuticals, Inc. Announces Results From Clinical Trials Of TRC105 In Patients With Ovarian Cancer To Be Presented At The 2014 Annual Meeting Of The European Society For Medical Oncology 9/25/2014 7:36:33 AM
San Diego's TRACON Pharmaceuticals, Inc. Reels In $27 Million 9/22/2014 6:01:42 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial Of TRC105 In Patients With Soft Tissue Sarcoma 9/4/2014 10:15:57 AM
TRACON Pharmaceuticals, Inc. Appoints William Larue To Its Board Of Directors 8/4/2014 9:01:57 AM
Santen Pharmaceutical And TRACON Pharmaceuticals, Inc. Announce Agreement For The Development And Commercialization Of TRC105 In Ophthalmology 3/4/2014 11:38:33 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study Of TRC105 In Patients With Advanced Soft Tissue Sarcoma 2/4/2014 9:27:32 AM
TRACON Pharmaceuticals, Inc. Initiates Phase 1b Study of TRC105 in Patients With Metastatic Renal Cell Carcinoma 9/24/2013 9:22:24 AM
TRACON Pharmaceuticals, Inc. Announces TRC105 Clinical Trials, Abstract Presentations at 2013 American Society of Clinical Oncology Annual Meeting 5/20/2013 6:47:46 AM
TRACON Pharmaceuticals, Inc. Announces Appointment of Kenneth Galbraith as Chairman of the Board 12/6/2011 10:07:42 AM
TRACON Pharmaceuticals, Inc. Announces $22 Million Tranched Investment Led by JAFCO and Nextech to Fund TRC105 Phase 2 Development 4/20/2011 6:50:10 AM
123
//-->